Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sambria Pharmaceuticals is a specialty pharmaceutical company focused on the development and commercialization of advanced topical pain management solutions. The company's flagship product line, NeuroMed, utilizes a proprietary delivery system designed to enhance the penetration and efficacy of lidocaine for various clinical applications. Their products are primarily used in dermatology, aesthetics, and for the treatment of neuropathic pain. Sambria aims to provide fast-acting, long-lasting relief with improved safety profiles compared to traditional topical anesthetics. The company targets healthcare professionals who require effective numbing agents for needle-based procedures and chronic pain conditions. By leveraging innovative formulation technology, Sambria continues to expand its presence in the specialty pharmaceutical market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sambria Pharmaceuticals.